AXYVER financials
A multi-period view of the public annual-account figures reported for AXYVER, with comparable measures and links to available source documents.
Company overviewRegistry number
0882174418
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for AXYVER
2025 versus 2024
- Operating line
- €89,270
- EBITDA
- €60,998
- Total assets
- €90,163
- Equity
- -€1,222,948
-21.3%
-22.7%
-64.1%
-9.4%
EBITDA margin +68.3% · Equity ratio -1,356.4%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €89,270 | €60,998 | €90,163 | -€1,222,948 | - |
| 202431 Dec 2024 | €113,496 | €78,937 | €251,335 | -€1,118,075 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.